Advertisement

Topics

Hemophilia Federation of America Company Profile

12:35 EDT 22nd September 2018 | BioPortfolio


News Articles [395 Associated News Articles listed on BioPortfolio]

Five Deaths in Genentech's Hemlibra Patients

The Hemophilia Federation of America and the National Hemophilia Foundation announced that they had been contacted by Genentech, a Roche company, about the deaths of five patients receiving Hemlibra (...

Roche to present new phase III data for Hemlibra in people with haemophilia A at the World Federation of Hemophilia 2018 World Congress

Roche today announced that phase III results for Hemlibra® (emicizumab) will be presented for the first time during the World Federation of Hemophilia (WFH) 2018 World Congress from 20-24 May in Glas...

Roche's hemophilia drug outperforms in clinical trials

Two clinical studies presented at the World Federation of Hemophilia congress in Glasgow, Scotland, showed that Roche Holding -More- 

Genentech’s Hemlibra Significantly Reduces Bleeding in Late-Stage Hemophilia Studies

Genentech’s hemophilia treatment Hemlibra continues to demonstrate its efficacy in treating patients. New late-stage data presented at World Federation of Hemophilia 2018 World Congress shows the dr...

Data Could Make Roche Drug a Hemophilia Standard, But for How Long?

It’s been a bumpy ride for emicizumab (Hemlibra) in 2018. The Roche/Genentech drug, approved by the FDA in late 2017, has a chance to become the choice treatment for people with hemophilia A, and ne...

Roche-Tochter Genentech informiert über Todesfälle bei Hämophilie-Patienten - Roche-Papiere drehen ins Plus

Wie auf der Internetseite der US-Patienten-Organisation Hemophilia Federation of America am Mittwoch zu lesen ist, wurde diese von Genentech über die Todesfälle informiert. Wie es dort weiter heiss....

Catalyst Biosciences Announces Oral Presentation at the World Federation of Hemophilia 2018 World Congress

SOUTH SAN FRANCISCO, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address h...

ASH to Collaborate on Clinical Practice Guidelines on Diagnosis and Management of von Willebrand Disease

WASHINGTON, June 21, 2018 /PRNewswire-USNewswire/ — The American Society of Hematology (ASH) will collaborate with the International Society on Thrombosis and Haemostasis (ISTH), National Hemoph...

Drugs and Medications [244 Associated Drugs and Medications listed on BioPortfolio]

Antimicrobial [Safetec of America]

Antimicrobial

A.b.h.c. instant hand sanitizer citrus scent [Safetec of America, Inc.]

A.B.H.C. INSTANT HAND SANITIZER

Hydrocortisone [Safetec of America, Inc.]

Safetec First Aid 1% Hydrocortisone Cream

Analgesic [Safetec of America, Inc.]

Safetec of America, Inc. PAIN SPRAY

Antiseptic [Safetec of America]

ANTISEPTIC – Benzalkonium chloride liquid Safetec of America

PubMed Articles [866 Associated PubMed Articles listed on BioPortfolio]

Haemophilia care in Latin America: Assessment and perspectives.

The study is the first application of the Principles of Haemophilia Care for Europe (PHCE) in other regions of the world, specifically in Latin America.

rFIXFc for Immune Tolerance Induction in a Severe Hemophilia B Patient with an Inhibitor and Prior History of ITI Related Nephrotic Syndrome.

Miracle of haemophilia drugs: Personal views about a few main players.

In the second decade of the third millennium there have been dramatic developments pertaining to the availability of highly innovative drugs for hemophilia care, notwithstanding a satisfactory previou...

Value of prophylaxis vs on-demand treatment: Application of a value framework in hemophilia.

Therapeutic advances over the past 30 years have led to longer life expectancy and improved quality of life (QOL) for persons with hemophilia. Access to innovative therapy may be compromised if treat...

Factor XI and pulmonary infections.

Clinical Trials [645 Associated Clinical Trials listed on BioPortfolio]

Study Evaluating ReFacto in Hemophilia A

To identify the causative mutations in previously untreated patients with hemophilia A enrolled in the ReFacto® clinical safety and efficacy study CTN 93-R833-0XX/C9741-28, using two esta...

Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

This trial is conducted in Africa, Asia, Europe, South America, and the United States of America (USA). The purpose of this study is to evaluate the effectiveness of secondary prophylacti...

ATHN 7: Hemophilia Natural History Study

This is a real-world study of the safety of the treatments used for people with hemophilia. The study will follow people with hemophilia A or B from across the country for about 4 years as...

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Retrospective, multicenter study in patients with hemophilia B. This study will be placed at 20 to 50 hemophilia treatment centers in North America and the EU, and is designed to estimate...

World Bleeding Disorders Registry

The World Federation of Hemophilia (WFH) is conducting the pilot phase of an international, retrospective and prospective, observational, World Bleeding Disorders Registry (WBDR). This pil...

Companies [1047 Associated Companies listed on BioPortfolio]

World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963,...

Hemophilia Federation of America

World Federation of Hemophilia

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and other inherited bleeding di...

NORSK INDUSTRI

On 28. November 2005 the new organisation Federation of Norwegian Industries was established. The new Federation will be formally operative as of 1. January 2006. From the start, the Federation of Nor...

The National Hemophilia Foundation

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education,...

More Information about "Hemophilia Federation of America" on BioPortfolio

We have published hundreds of Hemophilia Federation of America news stories on BioPortfolio along with dozens of Hemophilia Federation of America Clinical Trials and PubMed Articles about Hemophilia Federation of America for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hemophilia Federation of America Companies in our database. You can also find out about relevant Hemophilia Federation of America Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record